COEPW
Coeptis Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+0.00%Price chart
Mar 25Mar 30Apr 2Apr 8Apr 13Apr 16Apr 21Apr 24
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.4x
Market Cap
$49348.93
MomentumView details →
1D Return
+0.00%
YTD Return
−3.70%
RSI (14)
46.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.4x
Market Cap
$49348.93
RSI (14)
46.2
MomentumView details →
1D Return
+0.00%
YTD Return
−3.70%
SummaryUpdated Mar 1, 2026
Coeptis Therapeutics Holdings, Inc. (OTCMKTS:COEPW) is a biopharmaceutical company founded in 2017 and headquartered in Wexford, Pennsylvania. The company focuses on developing and commercializing both generic and branded pharmaceutical products, with a particular emphasis on innovative cell therapy platforms designed to treat various forms of cancer. Since its inception, Coeptis has evolved from a traditional pharmaceutical company into a biotechnology firm specializing in cutting-edge immunotherapy treatments, particularly those targeting specific cancer cell markers.
Similar companies
Latest newsMore news →
Z Squared Inc. entered into a sales agreement with Roth Capital Partners, LLC to offer and sell up to $300 million of its common stock in an at-the-market offering.60d agoZ Squared Inc. signed a $50 million committed equity forward purchase agreement on May 29, 2026, for the sale of its common stock in reliance on Section 4(a)(2) of the Securities Act and Regulation D.93d ago